Treace Medical Concepts (TMCI) Other Non-Current Assets (2022 - 2026)
Treace Medical Concepts (TMCI) posted Other Non-Current Assets of $1.5 million for Q1 2026, up 22.44% on a QoQ basis from $1.2 million in Q4 2025, and up 286.3% year-over-year from $387000.0 in Q1 2025.
Treace Medical Concepts (TMCI) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Treace Medical Concepts' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 286.3% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 286.3% YoY) and the FY2025 annual result came in at $1.2 million, up 200.0% from the prior year.
- Other Non-Current Assets was $1.5 million for Q1 2026 at Treace Medical Concepts, up from $1.2 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.5 million in Q1 2026 and bottomed at $134000.0 in Q1 2022.
- A 5-year average of $397823.5 and a median of $146000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 32.09% — and 2025, when it jumped 363.01%.
- Treace Medical Concepts' Other Non-Current Assets stood at $146000.0 in 2022, then changed by 0.0% to $146000.0 in 2023, then surged by 178.77% to $407000.0 in 2024, then jumped by 200.0% to $1.2 million in 2025, then climbed by 22.44% to $1.5 million in 2026.
- Business Quant data shows TMCI's Other Non-Current Assets at $1.5 million in Q1 2026, $1.2 million in Q4 2025, and $614000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 614,000.00 |
| Jun 30, 2025 | 676,000.00 |
| Mar 31, 2025 | 387,000.00 |
| Dec 31, 2024 | 407,000.00 |
| Sep 30, 2024 | 458,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | 146,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 146,000.00 |
| Mar 31, 2023 | 215,000.00 |
| Dec 31, 2022 | 146,000.00 |
| Sep 30, 2022 | 146,000.00 |
| Jun 30, 2022 | 134,000.00 |
| Mar 31, 2022 | 134,000.00 |